1. 25LBA Impact of baseline genetic heterogeneities on progression-free survival (PFS) in patients (pts) with advanced BRAFV600-mutated melanoma treated with cobimetinib (COBI) + vemurafenib (VEM) in the phase 3 coBRIM study. (September 2015) Authors: McArthur, G.; Larkin, J.; Dréno, B.; Ascierto, P.; Liszkay, G.; Maio, M.; Mandal´, M.; Demidov, L.; Stroyakovskiy, D.; Thomas, L.; De la Cruz-Merino, L.; Atkinson, V.; Dutriaux, C.; Garbe, C.; Wongchenko, M.; Hsu, J.; Koralek, D.; Rooney, I.; Yan, Y.; Ribas, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3340 Treatment beyond progression in advanced BRAF-mutated melanoma with vemurafenib and cobimetinib: Results from the BRIM7 trial. (September 2015) Authors: Lewis, K.; Ribas, A.; Gonzalez, R.; Hamid, O.; Daud, A.; Puzanov, I.; Hsu, J.; Choong, N.; Koralek, D.; McArthur, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CONTROLLED RELEASE OF CD200 INHIBITS INFLAMMATORY MACROPHAGES AND CHONDROCYTE CATABOLISM. (April 2022) Authors: Kumar, S.; Conklin, T.; Hsu, J.; Meli, V.; Chan, K.; Liu, W.; Allen, K.; Sharma, B. Journal: Osteoarthritis and cartilage Issue: Volume 30(2022)Supplement 1 Page Start: S69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: Pooled analysis of double-blind, placebo-controlled 6-week studies. (13th April 2021) Authors: Calisti, F.; Costamagna, I.; Hsu, J.; Tocco, M.; Pikalov, A.; Goldman, R. Journal: European psychiatry Issue: Volume 64:Supplement 1(2021) Page Start: S166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0103 Identification of optimal subcutaneous doses of tocilizumab in children with systemic juvenile idiopathic arthritis. (12th June 2018) Authors: Brunner, H.; Ruperto, N.; Lovell, D.; Calvo-Penedes, I.; Horneff, G.; Gamir Gamir, M.L.; Hufnagel, M.; Hsu, J.; Bao, M.; Douglass, W.; Mallalieu, N.L.; Wells, C.; Mela, C.M.; De Benedetti, F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P1061Long term PVC ablation success varies by source location. (20th June 2017) Authors: Krummen, DE.; Lee, D.; Pasek, T.; Ho, G.; Villongco, C.; Feld, G.; Schricker, AA.; Hsu, J.; Hoffmayer, KS. Journal: Europace Issue: Volume 19(2017)Supplement 3 Page Start: iii233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P258Complications and success rates associated with extraction and reimplantation of coronary sinus leads in patients with cardiac resynchronization devices. (20th June 2017) Authors: Kawata, H.; Green, UB.; Pollema, T.; Hsu, J.; Feld, G.; Pretorius, V. Journal: Europace Issue: Volume 19(2017)Supplement 3 Page Start: iii32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. STAR0602, a novel TCR agonist antibody, demonstrates potent antitumor activity in refractory solid tumor models through the expansion of a novel, polyclonal effector memory T cell subset. (October 2022) Authors: Gulley, J.L.; Bayliffe, A.; Donahue, R.; Tsai, Y.T.; Liu, K.; Katraggada, M.; Hsu, J.; Siu, L.L.; Wherry, E.J.; Chopra, R.; Schlom, J.; Su, Z. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. XL092, a multi-targeted inhibitor of MET, VEGFR2, AXL and MER with an optimized pharmacokinetic profile. (October 2020) Authors: Hsu, J.; Chong, C.; Goon, L.; Balayan, J.; Wu, S.; Johnson, E.; Lorenzana, G.; Bannen, L.; Nguyen, L.; Scheffold, C.; Lamb, P.; Xu, W.; Yu, P. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗